The recurrence of macular corneal dystrophy within a corneal graft has been described in a number of case reports. In this study, we reviewed 41 transplants in 31 eyes of 16 patients undergoing keratoplasty for macular corneal dystrophy con firmed by histopathological examination. The follow-up time ranged between 25 and 408 months from initial diagnosis. Six eyes of four patients had repeat keratoplasty because of clinical recurrence and visual impairment. Pathological confirmation was available in five of the six eyes. Peripheral clinical recurrence was observed in two more eyes. The size of the graft used was inversely related to the recurrence.
Macular corneal dystrophy (MCD) is a rare recessive disorder characterised clinically by the presence of bilateral opacities resulting from intra-and extra-cellular deposits within the corneal stroma. 1-3 This dystrophy was first described by Groenouw 100 years ago. 4 In patients with the disease, the opacities tend to be small, irregular and superficial during the first decade of life. The lesions then gradually increase to an advanced stage in which the entire thickness of the cornea is almost invar iably involved by the fourth decade and stro mal opacification reduces vision sufficiently to warrant penetrating keratoplastyl, 3 (PK).
Histochemically, MCD consists of the accu mulation of glycosaminoglycans within stro mal keratocytes and the surrounding stroma, in Bowman's layer, Descemet's membrane and the endothelium.5-8 Organ culture studies have recently indicated the presence of a defect in the synthesis of keratan sulphate proteoglycan. The replacement of keratan sulphate by a glycoprotein with similar immunological characteristics and with slightly smaller molecular weights has been proposed as the mechanism of the disease. 3 , 9, 1 0 Corneal thinning confirmed by pachymetry has recently been demonstrated but the reasons for this are obscure. 11 MCD may show heterogeneity in structure having at least three sub-groups that can be identified by immunohistochemical methods. 1 2,13 No corre lations, however, could be found between clinical features, staining characteristics, ultrastructural morphology and immunoreac tivity to keratan sulphate antibodies.
Keratoplasty is the only means of visual rehabilitation in the disease and after trans plantation the corneal graft remains clear for many years .14 The recurrence of dystrophic changes within the donor tissue is a recog nised complication.8,15-1 9 Initial lesions are usually seen in the peripheral donor stroma, involving both superficial and deep stromal layers. Later the graft itself may be compro mised by lesions resembling the primary dystrophy.
In the present study, the long-term prog nosis of 41 keratoplasties (39 PKs and 2lamel lar grafts [LK]) performed on 16 patients with MCD is reported. Particular reference is made to the reason for the failure of the orig inal graft and the need for repeat keratoplasty.
Patients and Methods
The files of all patients with MCD who had originally undergone keratoplasties in Moor fields Eye Hospital between 1964--1988 were reviewed to identify recurrence of the disease in the grafts. Factors analysed included age of onset, family history, age at keratoplasty, type of surgery and graft size, clinical recurrence, interval between PK and recurrence, repeat PK for recurrence, histopathology, other reason for graft failure and graft survival and follqw-up.
Bilateral grafts were performed in 15 patients and a unilateral graft was done in one case where amblyopia in the other eye pre cluded useful recovery of visual function. There were eight men and eight women in the study. A total of two lamellar and 39 pen etrating keratoplasties were performed in these 31 eyes.
Statistical analysis of recurrence in relation to graft size was by means of the Kruskal Wal lis variant of Wilcoxon rank sum test and the survival curve was produced by the standard Kaplan and Meier method. For the purposes of this paper, recurrence is defined as opacity, developing within the graft, dense enough to reduce substantially the patient's visual acuity and warrant repeat keratoplasty.
Results
The mean (±SEM) age when decreased vision was first noticed by the patient was 28 (±3) years). Nine (56%) patients reported at least one other individual in their families known to be affected. Parental consanguinity was noted in three patients (18%). The mean follow up period was 149 (±29) months. The mean age at the time of first keratoplasty was 41 (±4) years. Graft sizes ranged from 5-8 mm ( Figure 1 ). Figure 2 shows the course of the disease and the operations performed in all the patients. Of the 31 eyes of 16 patients studied, 24 (77.4 %) had only a single PK and this has remained clear. One patient had bilateral lamellar grafts initially. Recurrence of the dystrophy was seen at nine and 15 years respectively. Both eyes underwent sub- sequent PK and these grafts are clear nine and three years later. The probability curve of no recurrence of disease is shown in Figure 3 . All the ker atoplasties in this series are included and the graph suggests that there is a 50% probability of recurrence of MCD in a graft by about 19 years. MCD recurred in three first-time grafts (PKs). Repeat keratoplasty was performed in all three. One developed a rejection, failed and has subsequently undergone a further PK which is clear at this review, three years later. The other two remain clear, four and five years later.
Two first-time grafts suffered rejection epi sodes and failed. One has maintained a clear graft following repeat keratoplasty for five years, the other developed recurrence and was regrafted and this has remained clear three years later.
In all, six eyes of four patients were regrafted following clinical recurrence severe enough to reduce vision substantially ( Figures  4, 5, 6 ). Histopathological confirmation was available in five of these keratoplasties (Figures 7, 8 ).
The mean interval between initial PK and recurrence was 182 (±29) months. The mean follow-up period in cases with recurrent MCD was 264 (±53) whereas in those with clear grafts this was 111 (±27) months. This differ ence is significant, p<0.05. When the size of the graft was compared, those with recur rence (mean 6.37 (±0.47) mm) were signifi cantly smaller than those remaining clear (mean 7.52 (±0.06) mm) p<O.01.
Discussion
In patients with MCD and technically success ful grafts, the donor tissue remains transpar ent in the absence of rejection for many years. 18 Recurrence of the dystrophy has been reported as early as three years after trans plantation. 15 . 1 6 Histologically documented recurrences are most prominent in the periph eral cornea and this may indicate that the disease is caused by gradual invasion of the donor tissue by adjacent fibroblasts or ker atocytes from the host cornea. 3 ,1 8 , 20
The recurrence of MCD was first noted by Klintworth and Vogel 8 who reported muco polysaccharide deposits in donor tissues two- five years after PK. Soon afterwards Morganl5 showed recurrence of disease in the donor button three years after original transplanta tion. In 1967, Lorenzetti and Kaufman1 6 reported a patient with MCD whose grafts became opaque 20 and 27 months after bilat eral corneal grafting and cataract extraction. They found recurrent disease in the corneal stroma and the endothelium of the graft and suggested that acid mucopolysaccharides may have diffused into the donor tissue causing recurrence. More recently Robin et al. 17 described another patient who had developed recurrent disease 11 years after lamellar ker atoplasty. Following penetrating keratoplasty the excised button had the characteristic find ings of MCD in the donor. Klintworth et al. 1 8 published two further cases requiring PK 18 and 19 years following PK. Histochemical and electron microscopic features of MCD were demonstrated in the grafts. They communi cated that of 198 known patients with MCD in the USA only five (2.5%) had visual impair ment severe enough to warrant repeat ker atoplasty. Since most of these 198 grafts are not under continuous review by the authors it seems probable that this may represent con siderable under reporting of the true inci dence. Font et al. 19 have also reported one case of recurrence in a graft 30 years following PK in which the indication for repeat ker atoplasty was endothelial failure. In our group of patients with long and regular fol low-up within the same institution, clinical recurrence was 19.3% of which 83.3% were pathologically confirmed. If peripheral lesions are included the total recurrence rate is 25.8%. Reported recurrence times are between 20 months and 30 years. 8 ,15-19 In the present study the mean recurrence time was 182 months but the actuarial curve indicates that there is a 50% chance of recurrence within a graft at 18 years. Only a very few patients have been followed for longer than 20 years. It is worth noting however that as ker atoplasty was developing 20 years ago smaller grafts were much more common than now adays, Our results indicate an inverse relationship between size of graft and like lihood of recurrence and it may be that with increasing donor size there will be a conse quent increase in graft survival. We have no data, nor could we find any published work, to indicate that different methods of corneal donor storage would influence the rate of recurrence.
Lamellar keratoplasty has not been con sidered preferable for the treatment of MCD since the host corneal stroma is not removed completely.14.1 8 Klintworth et al. 1 8 proposed that diseased keratocytes migrating from the host into the donor tissue were responsible for the recurrence thus explaining the tendency of the lesions to be more pronounced in the peripheral grafted cornea. The pattern of the interface recurrence in our two grafts from the one patient who had lamellar grafts supports this contention.
Newsome et al. 2 0 indicated that a consider able amount of abnormal glycoprotein was synthesised by the host keratocytes. This pooled and was concentrated near the donor Descemet's membrane and eventually dif fused into the stroma. Using HLA typing methods they were also able to show donor keratocytes were still present in the grafts 25 years after transplantation. The inverse relationship found between graft size and the frequency of recurrence reported here is con sistent with these observations and may indi cate that smaller grafts are more readily invaded by abnormal glycoproteins and or stromal cells. Whether the loss of clarity results from depletion of donor keratocytes and the ingrowth of abnormal host kerato cytes or whether the remaining donor cells are overwhelmed by the abnormal metabolite is not yet clear. Furthermore, it is not clear whether the accumulation is due to an imbal ance of secretion alone or whether catabolism and removal of the metabolite is also impaired. It is possible that either defective synthesis or degradation or a combination of both is present in these patients and it is likely that MCD is a heterogenous group of dis orders rather than a single entity. 12 , 13 This may explain the selective rarity of recurrence in this condition and the variation between dif ferent populations and the patterns of disease. We did not observe endothelial cell accumulation of abnormal metabolite in any grafted cornea whereas it is a common phenomenon in the original specimens.
Patients with MCD undergoing kerato- plasty should be followed long term. They may require repeat keratoplasty when their vision is obscured by recurrence of MCD but larger sized grafts may delay or prevent this.
